Biopeople
 | This article contains content that is written like an advertisement. (July 2022) |
 | This article needs additional citations for verification. (June 2022) |
| Founded at | University of Copenhagen |
|---|---|
| Type | publicly fund |
| Purpose | global health and welfare |
Biopeople – Denmark's Life Science Cluster is a publicly funded partnership and National Center established, authorised, and funded by the Ministry for Science and Higher Education to improve innovation, collaboration and education within the National Danish Innovation System.[1] Biopeople is established as a Center at the Faculty of Health and Medical Sciences at University of Copenhagen.
Biopeople was the first European cluster organisation within health and life sciences to receive the recognition of Gold Label of the European Cluster Excellence Initiative (ECEI).
Biopeople helps academia and industry to co-create and develop ideas into new projects, products and services to benefit global health and welfare. Biopeople embraces and clusters universities, research organisations, and hospitals, the National Board of Health (Denmark) / Danish Health and Medical Authority, industry associations as well as pharma, medtech, medical device, food and biotech companies. The aim is to stimulate innovation through activities that bring researchers and stakeholders together across disciplines, sectors and public-private boundaries.
Structure
Biopeople embeds all relevant Danish stakeholders. It is a Center at University of Copenhagen. Member Companies affiliate by in-kind means by participating in innovation activities and projects. Companies include major large companies – fx Novo Nordisk, Lundbeck, LEO Pharma, Danisco, Novozymes, and Chr. Hansen – and many small and medium enterprises.
See also
- Clinical trial
- Contract Research Organization
- Drug development
- Drug design
- Drug discovery
- Functional beverage
- Health claims on food labels
- Medical food, specially formulated foods to treat diseases with distinctive nutritional needs (e.g., an inability to metabolize a common molecule)
- Nutraceuticals
- Nutrigenomics
- Preventive medicine
References
- ^ "Innovation Networks Denmark — Danish Agency for Science, Technology and Innovation". en.fi.dk. Archived from the original on 19 July 2012. Retrieved 22 May 2022.